{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:34Z","timestamp":1791827554556,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00439300"],"award-info":[{"award-number":["RS-2024-00439300"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00455804"],"award-info":[{"award-number":["RS-2024-00455804"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejpb.2025.114871","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:23:38Z","timestamp":1758086618000},"page":"114871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Film-forming system of optimized tacrolimus-loaded nanostructured lipid carriers for effective topical treatment of atopic dermatitis"],"prefix":"10.1016","volume":"216","author":[{"given":"Jin Sil","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Guk","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minki","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabsik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Suep","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-386X","authenticated-orcid":false,"given":"Hong-Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-0132","authenticated-orcid":false,"given":"Cheong-Weon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114871_b0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/cea.12495","article-title":"Pathogenesis of atopic dermatitis","volume":"45","author":"Peng","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ejpb.2025.114871_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","article-title":"Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejpb.2025.114871_b0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","article-title":"Atopic dermatitis: a disease of altered skin barrier and immune dysregulation","volume":"242","author":"Boguniewicz","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejpb.2025.114871_b0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.anai.2017.09.076","article-title":"Burden of skin pain in atopic dermatitis","volume":"119","author":"Vakharia","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejpb.2025.114871_b0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","article-title":"Japanese Dermatological Association, guidelines for management of atopic dermatitis","volume":"36","author":"Saeki","year":"2009","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejpb.2025.114871_b0030","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","article-title":"Dupilumab: a review of its use in the treatment of atopic dermatitis","volume":"78","author":"Gooderham","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2025.114871_b0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5414\/ALX02272E","article-title":"Janus kinase inhibitors for the therapy of atopic dermatitis","volume":"5","author":"Traidl","year":"2021","journal-title":"Allergol. Select"},{"key":"10.1016\/j.ejpb.2025.114871_b0040","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.jaad.2005.04.059","article-title":"The efficacy and safety of tacrolimus ointment: a clinical review","volume":"53","author":"Beck","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2025.114871_b0045","article-title":"Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis","volume":"618","author":"Paiva-Santos","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/17512433.2018.1449642","article-title":"Dupilumab for treatment of atopic dermatitis","volume":"11","author":"Seegr\u00e4ber","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114871_b0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/lt.21358","article-title":"Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon\u2010induced antiviral protein in human hepatocyte cells","volume":"14","author":"Hirano","year":"2008","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ejpb.2025.114871_b0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0162-3109(00)00187-9","article-title":"Applications of tacrolimus for the treatment of skin disorders","volume":"47","author":"Assmann","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejpb.2025.114871_b0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijpharm.2017.07.036","article-title":"Tacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: Structure characterization and in vitro\/in vivo performances","volume":"529","author":"Savi\u0107","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/gels8020129","article-title":"Tacrolimus-loaded solid lipid nanoparticle gel: Formulation development and in vitro assessment for topical applications","volume":"8","author":"Khan","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114871_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118918","article-title":"Formulation development of lipid nanoparticles: improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC)","volume":"576","author":"Kova\u010devi\u0107","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2010.03.047","article-title":"Tacrolimus-loaded liposomes for topical delivery: physicochemical characterization and in vivo evaluation","volume":"385","author":"Kim","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2019.03.042","article-title":"Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations","volume":"562","author":"Jain","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0090","first-page":"123","article-title":"Podophyllotoxin-tacrolimus nanostructured lipid carriers for enhanced skin delivery","volume":"12","author":"Chen","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114871_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/2230-973X.114899","article-title":"Self micro-emulsifying drug delivery system of tacrolimus: Formulation, in vitro evaluation and stability studies","volume":"3","author":"Patel","year":"2013","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2025.114871_b0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2012.03.042","article-title":"Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery","volume":"430","author":"Chen-yu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01920-3","article-title":"Emerging nanomedicines for the treatment of atopic dermatitis","volume":"22","author":"Parekh","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114871_b0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114871_b0115","first-page":"487","article-title":"Film forming systems for topical and transdermal drug delivery, asian","volume":"12","author":"Kathe","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114871_b0120","doi-asserted-by":"crossref","first-page":"S4119","DOI":"10.1088\/0953-8984\/17\/49\/008","article-title":"Solvent evaporation and interdiffusion in polymer films","volume":"17","author":"Tsige","year":"2005","journal-title":"J. Phys. Condens. Matter"},{"key":"10.1016\/j.ejpb.2025.114871_b0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.actbio.2019.10.024","article-title":"Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes","volume":"101","author":"Na","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2025.114871_b0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/cancers11060807","article-title":"The delivery strategy of paclitaxel nanostructured lipid carrier coated with platelet membrane","volume":"11","author":"Bang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejpb.2025.114871_b0135","article-title":"The combinative strategy for improving the intestinal stability and cellular absorption of curcumin by enteric coating of the optimized nanostructured lipid carriers","volume":"89","author":"Won","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114871_b0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/pharmaceutics11050222","article-title":"Systemic design and evaluation of ticagrelor-loaded nanostructured lipid carriers for enhancing bioavailability and antiplatelet activity","volume":"11","author":"Son","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114871_b0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.molliq.2016.03.069","article-title":"Application of Box\u2013Behnken design for preparation of glibenclamide loaded lipid based nanoparticles: Optimization, in vitro skin permeation, drug release and in vivo pharmacokinetic study","volume":"219","author":"Aslam","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2025.114871_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/21691401.2017.1408124","article-title":"Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: In vitro, ex vivo and in vivo assessments","volume":"46","author":"Soni","year":"2018","journal-title":"Artif. Cells Nanomed Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114871_b0155","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114871_b0160","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10717544.2014.885999","article-title":"Optimization of artemether-loaded NLC for intranasal delivery using central composite design","volume":"22","author":"Jain","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114871_b0165","doi-asserted-by":"crossref","first-page":"S3292","DOI":"10.1016\/j.arabjc.2013.12.028","article-title":"Use of response surface methodology for optimization of fluoride adsorption in an aqueous solution by Brushite","volume":"10","author":"Mourabet","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejpb.2025.114871_b0170","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1021\/acs.langmuir.0c03039","article-title":"Characterization of lipid nanoparticles containing ionizable cationic lipids using design-of-experiments approach","volume":"37","author":"Terada","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2025.114871_b0175","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s13346-022-01205-7","article-title":"Development of a long-acting tablet with ticagrelor high-loaded nanostructured lipid carriers","volume":"13","author":"Jung","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114871_b0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4103\/0250-474X.119820","article-title":"Optimization of paclitaxel containing pH-sensitive liposomes by 3 factor, 3 level box-behnken design","volume":"75","author":"Rane","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114871_b0185","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/21691401.2016.1167699","article-title":"Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box\u2013Behnken design approach","volume":"45","author":"Moghddam","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol"},{"key":"10.1016\/j.ejpb.2025.114871_b0190","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/pat.4684","article-title":"Film\u2010 and ointment\u2010based delivery systems for the transdermal delivery of TNP\u2010470","volume":"30","author":"Abramov","year":"2019","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ejpb.2025.114871_b0195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/pharmaceutics11060290","article-title":"Controlled release film forming systems in drug delivery: the potential for efficient drug delivery","volume":"11","author":"Tran","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114871_b0200","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/1346-8138.14489","article-title":"pH in nature, humans and skin","volume":"45","author":"Proksch","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejpb.2025.114871_b0205","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s13204-021-01744-4","article-title":"Tacrolimus-loaded chitosan-coated nanostructured lipid carriers: preparation, optimization and physicochemical characterization","volume":"11","author":"Dasineh","year":"2021","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.ejpb.2025.114871_b0210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/gels9070515","article-title":"Statistically optimized tacrolimus and thymoquinone co-loaded nanostructured lipid carriers gel for improved topical treatment of psoriasis","volume":"9","author":"Alam","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114871_b0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2011.03.056","article-title":"Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells","volume":"411","author":"Maupas","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114871_b0220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/10717544.2013.846435","article-title":"Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro","volume":"21","author":"Wang","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114871_b0225","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10787-023-01214-z","article-title":"Pterostilbene reduces the progression of atopic dermatitis via modulating inflammatory and oxidative stress biomarkers in mice","volume":"31","author":"Bangash","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejpb.2025.114871_b0230","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1038\/s41598-018-30404-x","article-title":"Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC\/Nga mice","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."}],"updated-by":[{"DOI":"10.1016\/j.ejpb.2025.114899","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000}},{"DOI":"10.1016\/j.ejpb.2025.114899","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:05:40Z","timestamp":1766095540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"alternative-id":["S0939641125002486"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114871","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Film-forming system of optimized tacrolimus-loaded nanostructured lipid carriers for effective topical treatment of atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114871"}}